Riskpilot← Back to searchSign inGet full accessCandoctors AB
ABActiveOrg 5592248271Johan Femmas Väg 1Engineering activities and related technical consultancy · NACE 7112Est. 20191 employees
Revenue 2025
SEK 2,8M
+8% vs 2024
EBITDA margin
23.4%
-27% vs 2024
Equity ratio
80.5%
Financial strength
Net profit 2025
SEK 487K
-24% vs 2024
| Revenue | SEK 2,8M | +8% |
| EBITDA | SEK 662K | -27% |
| Net profit | SEK 487K | -24% |
| Total assets | SEK 2,6M | +29% |
| Equity | SEK 2,1M | +30% |
| Employees | 1 | — |
Legal name
Candoctors AB
Org number
5592248271
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
31 oktober 2019
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet med fokus på bryggerisidan. Utveckling, tillverkning, produktion och försäljning av produkter till bryggeri och till den marina sidan. Återförsäljarverksamhet av produkter med global härkomst, främst från Tyskland, Schweiz och Kina (inom bryggeri och den marina sidan). Konsultverksamhet och försäljning av produkter kommer att ske globalt.
Address
Johan Femmas Väg 1
Email
mikael.leoni@candoctors.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 428 | 1 530 | 1 685 | 2 627 | 2 830 |
| Staff expenses | — | −729 | −737 | −754 | −1 054 |
| EBITDA | 387 | 349 | 530 | 910 | 662 |
| Depreciation & amort. | −0 | −37 | −162 | −113 | −79 |
| EBIT | 387 | 312 | 368 | 797 | 583 |
| Net financials | — | 8 | 8 | 8 | −23 |
| Profit before tax | 337 | 320 | 377 | 805 | 612 |
| Tax | −72 | −67 | −77 | −166 | −126 |
| Net profit | 265 | 253 | 299 | 639 | 487 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 068 | 1 409 | 1 251 | 2 045 | 2 636 |
| Equity | 445 | 698 | 997 | 1 636 | 2 123 |
| Long-term debt | 200 | 200 | 0 | — | — |
| Short-term debt | 320 | 408 | 151 | 305 | 463 |
| Total debt | 520 | 608 | 151 | 305 | 463 |
EBITDA margin
23.4%
This company
15.8%
Market median
+48% vs market
20212025
Equity ratio
80.5%
This company
38.2%
Market median
+111% vs market
20212025
Return on equity
22.9%
This company
18.4%
Market median
+24% vs market
20212025
Net profit margin
17.2%
This company
8.1%
Market median
+112% vs market
20212025
Asset turnover
1.07×
This company
1.12×
Market median
+4% vs market
20212025
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HM Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Candoctors AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Mikael Jörgen Leoni | Chief Executive Officer | 0 companies |
| Kersti Kristina Rolfsdotter Leoni | Deputy Board Member | 0 companies |